North America Pharmaceutical Plastic Packaging Market Industry Forecasts: Insights and Growth

North America Pharmaceutical Plastic Packaging Market by Raw Material (Polypropylene (PP), Polyethylene Terephthalate (PET), Low Density Polyethylene (LDPE), High Density Polyethylene (HDPE), Other Raw Materials), by Product Type** (Solid Containers, Dropper Bottles, Nasal Spray Bottles, Liquid Bottles, Oral Care, Pouches, Vials and Ampoules, Cartridges, Syringes, Caps and Closure, Other Product Types), by North America (United States, Canada, Mexico) Forecast 2026-2034

Aug 20 2025

Base Year: 2025

210 Pages

Key Insights

The North America pharmaceutical plastic packaging market, valued at approximately $16.51 billion in 2025, is projected to experience robust growth, driven by several key factors. The increasing demand for pharmaceutical products, coupled with the rising prevalence of chronic diseases, necessitates efficient and safe packaging solutions. Plastic packaging offers advantages like cost-effectiveness, lightweight nature, and barrier properties against moisture and oxygen, making it a preferred choice for drug manufacturers. Furthermore, advancements in plastic materials, such as the development of more sustainable and recyclable options, are fueling market expansion. The adoption of innovative packaging technologies, including tamper-evident closures and smart packaging incorporating RFID technology for enhanced traceability and security, is further contributing to market growth. However, growing environmental concerns regarding plastic waste and increasing regulatory scrutiny regarding the use of certain plastics in pharmaceutical packaging pose challenges to the market's sustained expansion. Companies are actively addressing these concerns through initiatives focused on improving recyclability and developing bio-based and biodegradable alternatives. This market is highly competitive, with major players focusing on product innovation, strategic partnerships, and geographic expansion to maintain a strong market position.

The forecast period from 2025 to 2033 anticipates a continued expansion of the North American pharmaceutical plastic packaging market, with the CAGR of 5.97% suggesting a significant increase in market value by 2033. This growth is expected to be driven by the ongoing development of new drugs and therapies, necessitating specialized packaging solutions. The increasing focus on personalized medicine and the rise of advanced drug delivery systems also contribute to the market's expansion. Regional variations in growth will likely be influenced by factors such as healthcare infrastructure development, regulatory frameworks, and consumer preferences. While the market faces challenges related to environmental concerns and cost pressures, the overall outlook remains positive due to the sustained demand for pharmaceutical products and the continuous advancements in packaging technologies. The leading companies in this sector are likely to witness enhanced revenue growth through strategic acquisitions, mergers, and development of sustainable packaging materials.

North America Pharmaceutical Plastic Packaging Market Market Size and Forecast (2024-2030) — North America Pharmaceutical Plastic Packaging Market Company Market Share

North America Pharmaceutical Plastic Packaging Market Report: 2019-2033

This comprehensive report provides an in-depth analysis of the North America pharmaceutical plastic packaging market, encompassing market dynamics, growth trends, regional analysis, product landscape, key players, and future outlook. The study period covers 2019-2033, with a base year of 2025 and a forecast period of 2025-2033. This report is crucial for industry professionals, investors, and stakeholders seeking to understand and capitalize on opportunities within this rapidly evolving market. The parent market is the broader North American packaging market, while the child market focuses specifically on pharmaceutical applications.

North America Pharmaceutical Plastic Packaging Market Dynamics & Structure

The North American pharmaceutical plastic packaging market is characterized by a moderately consolidated structure with several major players competing alongside numerous smaller niche players. Market concentration is influenced by factors like technological advancements, regulatory compliance, and the increasing demand for sustainable packaging solutions. The market size in 2025 is estimated at xx Million units.

Market Concentration: The top 5 players hold approximately xx% of the market share in 2025, reflecting a moderately competitive landscape.
Technological Innovation: Drivers include the development of sustainable materials (e.g., recycled plastics, bioplastics), advancements in barrier technologies, and increasing adoption of smart packaging solutions. Innovation barriers include high R&D costs and stringent regulatory approvals.
Regulatory Frameworks: Stringent regulations concerning drug safety and environmental protection significantly influence packaging choices and material selection. Compliance necessitates substantial investments in testing and certification.
Competitive Product Substitutes: While plastics remain dominant, alternatives like glass and paper-based packaging are gaining traction due to growing environmental concerns. Competition among materials drives innovation and efficiency improvements.
End-User Demographics: The market is driven by the aging population, increasing prevalence of chronic diseases, and rising demand for convenient and safe medication delivery systems.
M&A Trends: The past five years have seen xx M&A deals in the North American pharmaceutical plastic packaging market, mainly driven by efforts to expand product portfolios and geographical reach. Larger companies are actively consolidating smaller players.

North America Pharmaceutical Plastic Packaging Market Growth Trends & Insights

The North America pharmaceutical plastic packaging market is projected to exhibit a CAGR of xx% during the forecast period (2025-2033). Market size expansion is driven by several key factors, including the rising adoption of single-use packaging, increasing demand for tamper-evident and child-resistant packaging, and the growing focus on sustainable and eco-friendly packaging solutions. Market penetration of innovative packaging technologies, such as active and intelligent packaging, is expected to increase at a rate of xx% annually. Consumer preference for convenient and user-friendly drug packaging solutions contributes to market growth. Technological disruptions, particularly in material science and automation, further fuel market expansion.

Dominant Regions, Countries, or Segments in North America Pharmaceutical Plastic Packaging Market

The United States dominates the North America pharmaceutical plastic packaging market, accounting for approximately xx% of the total market value in 2025. This dominance is primarily attributed to its large pharmaceutical industry, robust healthcare infrastructure, and high per capita healthcare expenditure.

Key Drivers in the US: Strong pharmaceutical R&D, robust healthcare infrastructure, high consumer spending on healthcare, and supportive regulatory frameworks contribute to the US market's dominance.
Growth Potential in Canada: Canada exhibits considerable growth potential, driven by increasing healthcare investment and the growing adoption of advanced packaging solutions.
Segment Dominance: Blister packs hold a significant market share due to their cost-effectiveness and suitability for various drug forms. However, the demand for sustainable alternatives is increasing the prominence of eco-friendly options like HDPE-based packaging.

North America Pharmaceutical Plastic Packaging Market Product Landscape

The market offers a wide array of plastic packaging solutions, including blisters, bottles, vials, tubes, and closures, each tailored to specific pharmaceutical products and delivery methods. Recent innovations focus on enhancing barrier properties, improving tamper evidence, and incorporating features that enhance patient convenience and medication adherence. Sustainable and recyclable packaging is gaining prominence, driven by environmental concerns and regulatory pressures.

Key Drivers, Barriers & Challenges in North America Pharmaceutical Plastic Packaging Market

Key Drivers:

The rising demand for convenient and safe drug delivery systems.
Increasing focus on patient compliance and adherence.
The growing adoption of single-dose packaging formats.
Stringent regulations necessitating safe and tamper-evident packaging.

Key Challenges:

Fluctuations in raw material prices impacting production costs.
Stringent regulatory approvals and compliance requirements.
The growing preference for sustainable packaging creates challenges in material sourcing and cost management. The transition to sustainable materials often involves higher initial investment.

Emerging Opportunities in North America Pharmaceutical Plastic Packaging Market

Emerging opportunities include the expansion of sustainable and eco-friendly packaging solutions, particularly those utilizing recycled plastics and bio-based materials. Increased adoption of smart packaging with integrated sensors and track-and-trace features represents another significant growth avenue. The integration of digital technologies, such as QR codes, for enhanced patient information and medication management will drive innovation.

Growth Accelerators in the North America Pharmaceutical Plastic Packaging Market Industry

Technological advancements in material science, automation, and packaging design are key growth catalysts. Strategic collaborations between packaging manufacturers and pharmaceutical companies streamline supply chains and accelerate the development of innovative solutions. Expansion into niche segments, such as personalized medicine and specialty pharmaceuticals, presents additional opportunities for growth.

Key Players Shaping the North America Pharmaceutical Plastic Packaging Market Market

Gerresheimer AG
Amcor Group GmbH
Berry Global Group Inc
Comar LLC
Klockner Pentaplast Group
Nipro Medical Corporation
James Alexander Corporation
Drug Plastics Group
Pretium Packaging
Bormioli Pharma United States Inc (Bormioli Pharma S p A )
Silgan Plastics (Silgan Holdings Inc)
*List Not Exhaustive

Notable Milestones in North America Pharmaceutical Plastic Packaging Market Sector

July 2024: Amcor Group GmbH’s AmSky™ and AmPrima™ recognition and inclusion in Walmart’s Circular Connector platform highlights the growing demand for sustainable pharmaceutical packaging.
April 2024: Berry Global Group, Inc.’s launch of a lightweight tube closure solution using recycled plastics showcases the industry's commitment to environmental responsibility and reduced carbon footprint.

In-Depth North America Pharmaceutical Plastic Packaging Market Market Outlook

The North America pharmaceutical plastic packaging market is poised for continued growth, driven by technological innovation, increased demand for sustainable solutions, and the expanding pharmaceutical industry. Strategic partnerships, investments in R&D, and expansion into new markets will be crucial for companies to capitalize on the substantial market potential. The focus on sustainability and improved patient experiences will shape future market trends.

North America Pharmaceutical Plastic Packaging Market Segmentation

1. Raw Material
- 1.1. Polypropylene (PP)
- 1.2. Polyethylene Terephthalate (PET)
- 1.3. Low Density Polyethylene (LDPE)
- 1.4. High Density Polyethylene (HDPE)
- 1.5. Other Raw Materials
2. Product Type**
- 2.1. Solid Containers
- 2.2. Dropper Bottles
- 2.3. Nasal Spray Bottles
- 2.4. Liquid Bottles
- 2.5. Oral Care
- 2.6. Pouches
- 2.7. Vials and Ampoules
- 2.8. Cartridges
- 2.9. Syringes
- 2.10. Caps and Closure
- 2.11. Other Product Types

North America Pharmaceutical Plastic Packaging Market Segmentation By Geography

1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico

North America Pharmaceutical Plastic Packaging Market Market Share by Region - Global Geographic Distribution — North America Pharmaceutical Plastic Packaging Market Regional Market Share

Geographic Coverage of North America Pharmaceutical Plastic Packaging Market

Higher Coverage

Lower Coverage

No Coverage

North America Pharmaceutical Plastic Packaging Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 5.97% from 2020-2034
Segmentation	By Raw Material Polypropylene (PP) Polyethylene Terephthalate (PET) Low Density Polyethylene (LDPE) High Density Polyethylene (HDPE) Other Raw Materials By Product Type** Solid Containers Dropper Bottles Nasal Spray Bottles Liquid Bottles Oral Care Pouches Vials and Ampoules Cartridges Syringes Caps and Closure Other Product Types By Geography North America United States Canada Mexico

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
- - 3.3. Market Restrains
  - - 3.3.1. Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
- - 3.4. Market Trends
  - - 3.4.1. Rising Demand for Sealed and Protective Caps and Closure for Pharmaceutical Containers
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. North America Pharmaceutical Plastic Packaging Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
  - 5.1.1. Polypropylene (PP)
  - 5.1.2. Polyethylene Terephthalate (PET)
  - 5.1.3. Low Density Polyethylene (LDPE)
  - 5.1.4. High Density Polyethylene (HDPE)
  - 5.1.5. Other Raw Materials
- 5.2. Market Analysis, Insights and Forecast - by Product Type**
  - 5.2.1. Solid Containers
  - 5.2.2. Dropper Bottles
  - 5.2.3. Nasal Spray Bottles
  - 5.2.4. Liquid Bottles
  - 5.2.5. Oral Care
  - 5.2.6. Pouches
  - 5.2.7. Vials and Ampoules
  - 5.2.8. Cartridges
  - 5.2.9. Syringes
  - 5.2.10. Caps and Closure
  - 5.2.11. Other Product Types
- 5.3. Market Analysis, Insights and Forecast - by Region
  - 5.3.1. North America
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Gerresheimer AG
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Amcor Group GmbH
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Berry Global Group Inc
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Comar LLC
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Klockner Pentaplast Group
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Nipro Medical Corporation
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 James Alexander Corporation
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Drug Plastics Group
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Pretium Packaging
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)
    - 6.2.10 Bormioli Pharma United States Inc (Bormioli Pharma S p A )
      6.2.10.1. Overview
      6.2.10.2. Products
      6.2.10.3. SWOT Analysis
      6.2.10.4. Recent Developments
      6.2.10.5. Financials (Based on Availability)
    - 6.2.11 Silgan Plastics (Silgan Holdings Inc )*List Not Exhaustive
      6.2.11.1. Overview
      6.2.11.2. Products
      6.2.11.3. SWOT Analysis
      6.2.11.4. Recent Developments
      6.2.11.5. Financials (Based on Availability)

List of Figures

Figure 1: North America Pharmaceutical Plastic Packaging Market Revenue Breakdown (Million, %) by Product 2025 & 2033
Figure 2: North America Pharmaceutical Plastic Packaging Market Share (%) by Company 2025

List of Tables

Table 1: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2020 & 2033
Table 2: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2020 & 2033
Table 3: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type** 2020 & 2033
Table 4: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type** 2020 & 2033
Table 5: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Region 2020 & 2033
Table 6: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Region 2020 & 2033
Table 7: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2020 & 2033
Table 8: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2020 & 2033
Table 9: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type** 2020 & 2033
Table 10: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type** 2020 & 2033
Table 11: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Country 2020 & 2033
Table 12: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Country 2020 & 2033
Table 13: United States North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2020 & 2033
Table 14: United States North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2020 & 2033
Table 15: Canada North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2020 & 2033
Table 16: Canada North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2020 & 2033
Table 17: Mexico North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2020 & 2033
Table 18: Mexico North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2020 & 2033

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Pharmaceutical Plastic Packaging Market?

The projected CAGR is approximately 5.97%.

2. Which companies are prominent players in the North America Pharmaceutical Plastic Packaging Market?

Key companies in the market include Gerresheimer AG, Amcor Group GmbH, Berry Global Group Inc, Comar LLC, Klockner Pentaplast Group, Nipro Medical Corporation, James Alexander Corporation, Drug Plastics Group, Pretium Packaging, Bormioli Pharma United States Inc (Bormioli Pharma S p A ), Silgan Plastics (Silgan Holdings Inc )*List Not Exhaustive.

3. What are the main segments of the North America Pharmaceutical Plastic Packaging Market?

The market segments include Raw Material, Product Type**.

4. Can you provide details about the market size?

The market size is estimated to be USD 16.51 Million as of 2022.

5. What are some drivers contributing to market growth?

Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales.

6. What are the notable trends driving market growth?

Rising Demand for Sealed and Protective Caps and Closure for Pharmaceutical Containers.

7. Are there any restraints impacting market growth?

Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales.

8. Can you provide examples of recent developments in the market?

July 2024: Amcor Group GmbH completed nine months of receiving recognition for its AmSky™ and AmPrima™, which helped the company earn a place on Walmart’s Circular Connector platform. AmSky is a polyvinyl chloride (PVC) and aluminum-free recycle-ready blister pack for pharmaceuticals. Disrupting the decades-long, over-the-counter standard drug pack, it uses high-density polyethylene (HDPE). AmPrima is a portfolio of recycle-ready packaging solutions for both solid and liquid content.April 2024: Berry Global Group, Inc. completed six months since the launch of a lightweight tube closure solution. This innovative closure, crafted from either virgin polyethylene (PE) and polypropylene (PP) or food-safe post-consumer recycled plastics (rPE and rPP), significantly contributes to reducing greenhouse gas emissions. It is particularly suited for personal care and pharmaceutical applications.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 4950, and USD 6800 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in Million and volume, measured in Billion.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "North America Pharmaceutical Plastic Packaging Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the North America Pharmaceutical Plastic Packaging Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the North America Pharmaceutical Plastic Packaging Market?

To stay informed about further developments, trends, and reports in the North America Pharmaceutical Plastic Packaging Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

About Nexa Reports

Nexa Reports delivers innovative market research, industry trends, and strategic analysis for global businesses. Our reports cover technology, pharmaceuticals, renewable energy, and financial services, providing the insights you need to make confident decisions.

Our expert team combines primary research, data analytics, and sector expertise to deliver actionable intelligence. We offer both syndicated and custom research solutions tailored to your business needs.

At Nexa Reports, we are committed to quality, integrity, and client satisfaction. Every report is rigorously validated and peer-reviewed for accuracy and reliability. Our global reach and local expertise ensure you understand both macro trends and micro market dynamics.

Stay ahead with Nexa Reports. Subscribe to our newsletter for the latest industry updates and research highlights, and follow us on social media for real-time insights.

Nexa Reports – Your Source for Forward-Thinking Market Intelligence.